| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
in Lung Cancer1
Division of Hematology/Oncology, Departments of Medicine [B. H., D. D. K.] and Pathology [O. K.], Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, and Harvard Institutes of Medicine, Harvard Medical School [C. S. H., D. G. T.] and Department of Dermatology, Brigham and Womens Hospital, HIM-660 [K. F.], Boston, Massachusetts 02115
The transcription factor, CCAAT/enhancer binding protein
(C/EBP
) is important in the terminal differentiation of granulocytes, hepatocytes, and adipocytes, and recurrent mutations of C/EBP
were described in acute myeloid leukemia. In the lung, C/EBP
is expressed in bronchial cells and type II pneumocytes. Abnormal proliferation of the latter cell type was reported in C/EBP
knockout mice. We determined the expression of C/EBP
by Northern blot analysis in 30 lung cancer cell lines and found significant down-regulation in 24 cell lines. Immunohistochemical study of primary tumor specimens showed undetectable or low expression of C/EBP
in 23 of 53 specimens. Its expression was more frequently down-regulated in adenocarcinoma and poorly differentiated cancer specimens than in squamous cell cancers. A higher frequency of reduced expression was found in more advanced stages. To investigate the consequences of C/EBP
expression in lung cancer cells, we stably transfected two cell lines that do not express the gene (Calu1 and H358) with a plasmid allowing for induction of C/EBP
protein expression. Induction of C/EBP
led to significant growth reduction attributable to proliferation arrest, morphological changes characteristic of differentiation, and apoptosis. These results suggest that C/EBP
is down-regulated in a large proportion of lung cancers and that it has growth-inhibitory properties in airway epithelial cells. Genetic analysis of the C/EBP
gene is in progress to fully evaluate its role as a novel tumor suppressor in lung cancer.
This article has been cited by other articles:
![]() |
S. D. N. Reddy, S. B. Pakala, K. Ohshiro, S. K. Rayala, and R. Kumar MicroRNA-661, a c/EBP{alpha} Target, Inhibits Metastatic Tumor Antigen 1 and Regulates Its Functions Cancer Res., July 15, 2009; 69(14): 5639 - 5642. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. SEIFEDDINE, M.-C. FULCHIGNONI-LATAUD, and L. MASSAAD-MASSADE Down-regulation of C/EBP{alpha} in Breast Cancer Cells by Hypoxia-Estrogen Combination is Mainly Due to Hypoxia Anticancer Res, April 1, 2009; 29(4): 1227 - 1231. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Koschmieder, B. Halmos, E. Levantini, and D. G. Tenen Dysregulation of the C/EBP{alpha} Differentiation Pathway in Human Cancer J. Clin. Oncol., February 1, 2009; 27(4): 619 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dhawan, R. Weider, and S. Christakos CCAAT Enhancer-binding Protein {alpha} Is a Molecular Target of 1,25-Dihydroxyvitamin D3 in MCF-7 Breast Cancer Cells J. Biol. Chem., January 30, 2009; 284(5): 3086 - 3095. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Huang, R. Eisenberg, M. Yan, S. Monti, E. Lawrence, P. Fu, J. Walbroehl, E. Lowenberg, T. Golub, J. Merchan, et al. 15-Hydroxyprostaglandin Dehydrogenase is a Target of Hepatocyte Nuclear Factor 3{beta} and a Tumor Suppressor in Lung Cancer Cancer Res., July 1, 2008; 68(13): 5040 - 5048. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Wu, J.-C. Lin, S.-C. Yang, C.-W. Lin, J. J.W. Chen, J.-Y. Shih, T.-M. Hong, and P.-C. Yang Modulation of the expression of the invasion-suppressor CRMP-1 by cyclooxygenase-2 inhibition via reciprocal regulation of Sp1 and C/EBP{alpha} Mol. Cancer Ther., June 1, 2008; 7(6): 1365 - 1375. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Seifeddine, A. Dreiem, E. Blanc, M.-C. Fulchignoni-Lataud, M.-A. L. F. Belda, F. Lecuru, T. H. Mayi, N. Mazure, V. Favaudon, C. Massaad, et al. Hypoxia Down-regulates CCAAT/Enhancer Binding Protein-{alpha} Expression in Breast Cancer Cells Cancer Res., April 1, 2008; 68(7): 2158 - 2165. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cheng, D. V. Yu, J.-H. Zhou, and D. J. Shapiro Tamoxifen Induction of CCAAT Enhancer-binding Protein {alpha} Is Required for Tamoxifen-induced Apoptosis J. Biol. Chem., October 19, 2007; 282(42): 30535 - 30543. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kendall, Q. Liu, A. Bakleh, A. Krasnitz, K. C. Q. Nguyen, B. Lakshmi, W. L. Gerald, S. Powers, and D. Mu Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer PNAS, October 16, 2007; 104(42): 16663 - 16668. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Loomis, S. Zhu, K. Yoon, P. F. Johnson, and R. C. Smart Genetic Ablation of CCAAT/Enhancer Binding Protein {alpha} in Epidermis Reveals Its Role in Suppression of Epithelial Tumorigenesis Cancer Res., July 15, 2007; 67(14): 6768 - 6776. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Bennett, B. Hackanson, L. T. Smith, C. D. Morrison, J. C. Lang, D. E. Schuller, F. Weber, C. Eng, and C. Plass Tumor Suppressor Activity of CCAAT/Enhancer Binding Protein {alpha} Is Epigenetically Down-regulated in Head and Neck Squamous Cell Carcinoma Cancer Res., May 15, 2007; 67(10): 4657 - 4664. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Agrawal, W.-K. Hofmann, N. Tidow, M. Ehrich, D. v. d. Boom, S. Koschmieder, W. E. Berdel, H. Serve, and C. Muller-Tidow The C/EBP{delta} tumor suppressor is silenced by hypermethylation in acute myeloid leukemia Blood, May 1, 2007; 109(9): 3895 - 3905. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Chapiro, L. Russell, I. Radford-Weiss, C. Bastard, M. Lessard, S. Struski, H. Cave, S. Fert-Ferrer, C. Barin, O. Maarek, et al. Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia Blood, November 15, 2006; 108(10): 3560 - 3563. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Berg, L. Didon, and M. Nord Ectopic expression of C/EBP{alpha} in the lung epithelium disrupts late lung development Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L683 - L693. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yin and J. Glass In Prostate Cancer Cells the Interaction of C/EBP{alpha} with Ku70, Ku80, and Poly(ADP-ribose) Polymerase-1 Increases Sensitivity to DNA Damage J. Biol. Chem., April 28, 2006; 281(17): 11496 - 11505. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tada, R. M. Brena, B. Hackanson, C. Morrison, G. A. Otterson, and C. Plass Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. J Natl Cancer Inst, March 15, 2006; 98(6): 396 - 406. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Martis, J. A. Whitsett, Y. Xu, A.-K. T. Perl, H. Wan, and M. Ikegami C/EBP{alpha} is required for lung maturation at birth Development, March 15, 2006; 133(6): 1155 - 1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Basseres, E. Levantini, H. Ji, S. Monti, S. Elf, T. Dayaram, M. Fenyus, O. Kocher, T. Golub, K.-k. Wong, et al. Respiratory Failure Due to Differentiation Arrest and Expansion of Alveolar Cells following Lung-Specific Loss of the Transcription Factor C/EBP{alpha} in Mice Mol. Cell. Biol., February 1, 2006; 26(3): 1109 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gery, A. F. Gombart, W. S. Yi, C. Koeffler, W.-K. Hofmann, and H. P. Koeffler Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia Blood, October 15, 2005; 106(8): 2827 - 2836. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Johnson Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors J. Cell Sci., June 15, 2005; 118(12): 2545 - 2555. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ikezoe, S. Gery, D. Yin, J. O'Kelly, L. Binderup, N. Lemp, H. Taguchi, and H. P. Koeffler CCAAT/Enhancer-Binding Protein {delta}: A Molecular Target of 1,25-Dihydroxyvitamin D3 in Androgen-Responsive Prostate Cancer LNCaP Cells Cancer Res., June 1, 2005; 65(11): 4762 - 4768. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Takai, N. Kawamata, C. S. Walsh, S. Gery, J. C. Desmond, S. Whittaker, J. W. Said, L. M. Popoviciu, P. A. Jones, I. Miyakawa, et al. Discovery of Epigenetically Masked Tumor Suppressor Genes in Endometrial Cancer Mol. Cancer Res., May 1, 2005; 3(5): 261 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gery, S. Tanosaki, S. Bose, N. Bose, J. Vadgama, and H. P. Koeffler Down-Regulation and Growth Inhibitory Role of C/EBP{alpha} in Breast Cancer Clin. Cancer Res., May 1, 2005; 11(9): 3184 - 3190. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shim, K. L. Powers, S. J. Ewing, S. Zhu, and R. C. Smart Diminished Expression of C/EBP{alpha} in Skin Carcinomas Is Linked to Oncogenic Ras and Reexpression of C/EBP{alpha} in Carcinoma Cells Inhibits Proliferation Cancer Res., February 1, 2005; 65(3): 861 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. GRISENDI and P.P. PANDOLFI Two Decades of Cancer Genetics: From Specificity to Pleiotropic Networks Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 83 - 91. [Abstract] [PDF] |
||||
![]() |
K. Yoon and R. C. Smart C/EBP{alpha} Is a DNA Damage-Inducible p53-Regulated Mediator of the G1 Checkpoint in Keratinocytes Mol. Cell. Biol., December 15, 2004; 24(24): 10650 - 10660. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Halmos, D. S. Basseres, S. Monti, F. D'Alo, T. Dayaram, K. Ferenczi, B. J. Wouters, C. S. Huettner, T. R. Golub, and D. G. Tenen A Transcriptional Profiling Study of CCAAT/Enhancer Binding Protein Targets Identifies Hepatocyte Nuclear Factor 3{beta} as a Novel Tumor Suppressor in Lung Cancer Cancer Res., June 15, 2004; 64(12): 4137 - 4147. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Ross, H. S. Radomska, B. Wu, P. Zhang, J. N. Winnay, L. Bajnok, W. S. Wright, F. Schaufele, D. G. Tenen, and O. A. MacDougald Phosphorylation of C/EBP{alpha} Inhibits Granulopoiesis Mol. Cell. Biol., January 15, 2004; 24(2): 675 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. N. Cassel and M. Nord C/EBP transcription factors in the lung epithelium Am J Physiol Lung Cell Mol Physiol, October 1, 2003; 285(4): L773 - L781. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |